48,453
edits
Difference between revisions of "Urothelial dysplasia"
Jump to navigation
Jump to search
→Sign out
(+infobox) |
|||
| (19 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{ Infobox diagnosis | {{ Infobox diagnosis | ||
| Name = {{PAGENAME}} | | Name = {{PAGENAME}} | ||
| Image = | | Image = Urothelial dysplasia - alt -- high mag.jpg | ||
| Width = | | Width = | ||
| Caption = | | Caption = Urothelial dysplasia. [[H&E stain]]. | ||
| Synonyms = low-grade urothelial dysplasia | | Synonyms = low-grade urothelial dysplasia | ||
| Micro = mild nuclear enlargement (~3x a resting lymphocyte) and hyperchromasia, mild disorganization of the architecture (some maturation), occasional mitotic figures - none atypical | | Micro = mild nuclear enlargement (~3x a resting lymphocyte) and hyperchromasia, mild disorganization of the architecture (some maturation), occasional mitotic figures - none atypical | ||
| Subtypes = | | Subtypes = | ||
| LMDDx = reactive changes, [[urothelial carcinoma in situ]] | | LMDDx = reactive changes, urothelial atypia of unknown significance, [[urothelial carcinoma in situ]] | ||
| Stains = | | Stains = | ||
| IHC = CK20 +ve/-ve (esp. non-umbrella cells), Ki-67 +ve/-ve (>10%), p53 +ve/-ve (>20%) | | IHC = CK20 +ve/-ve (esp. non-umbrella cells), Ki-67 +ve/-ve (>10%), p53 +ve/-ve (>20%) | ||
| Line 35: | Line 35: | ||
==General== | ==General== | ||
The ISUP/WHO classification of flat urothelial lesions is:<ref name=pmid19762067>{{Cite journal | last1 = Hodges | first1 = KB. | last2 = Lopez-Beltran | first2 = A. | last3 = Davidson | first3 = DD. | last4 = Montironi | first4 = R. | last5 = Cheng | first5 = L. | title = Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features. | journal = Hum Pathol | volume = 41 | issue = 2 | pages = 155-62 | month = Feb | year = 2010 | doi = 10.1016/j.humpath.2009.07.002 | PMID = 19762067 }}</ref> | The [[ISUP]]/WHO classification of flat urothelial lesions is:<ref name=pmid19762067>{{Cite journal | last1 = Hodges | first1 = KB. | last2 = Lopez-Beltran | first2 = A. | last3 = Davidson | first3 = DD. | last4 = Montironi | first4 = R. | last5 = Cheng | first5 = L. | title = Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features. | journal = Hum Pathol | volume = 41 | issue = 2 | pages = 155-62 | month = Feb | year = 2010 | doi = 10.1016/j.humpath.2009.07.002 | PMID = 19762067 }}</ref> | ||
*Reactive urothelial atypia. | *Reactive urothelial atypia. | ||
*Flat urothelial hyperplasia. | *Flat urothelial hyperplasia. | ||
| Line 47: | Line 47: | ||
*Mild nuclear enlargement (~3x a resting lymphocyte) and hyperchromasia. | *Mild nuclear enlargement (~3x a resting lymphocyte) and hyperchromasia. | ||
*Slight disorganization of the architecture. | *Slight disorganization of the architecture. | ||
**Some maturation to the surface. | **Some maturation to the surface - '''important'''. | ||
*Mitotic figures - occasional, none atypical. | *Mitotic figures - occasional, none atypical. | ||
| Line 56: | Line 56: | ||
DDx: | DDx: | ||
*Benign urothelium with reactive changes. | *Benign urothelium with reactive changes. | ||
*[[Urothelial carcinoma in situ]]. | *[[Urothelial carcinoma in situ]] - no maturation to the surface or marked atypia - as in pagetoid [[UCIS]] and undermining UCIS.<ref name=pmid11224606>{{Cite journal | last1 = McKenney | first1 = JK. | last2 = Gomez | first2 = JA. | last3 = Desai | first3 = S. | last4 = Lee | first4 = MW. | last5 = Amin | first5 = MB. | title = Morphologic expressions of urothelial carcinoma in situ: a detailed evaluation of its histologic patterns with emphasis on carcinoma in situ with microinvasion. | journal = Am J Surg Pathol | volume = 25 | issue = 3 | pages = 356-62 | month = Mar | year = 2001 | doi = | PMID = 11224606 }}</ref> | ||
===Images=== | ===Images=== | ||
<gallery> | |||
Image: Urothelial dysplasia -- low mag.jpg | UD - low mag. (WC) | |||
Image: Urothelial dysplasia -- intermed mag.jpg | UD - intermed. mag. (WC) | |||
Image: Urothelial dysplasia -- high mag.jpg | UD - high mag. (WC) | |||
Image: Urothelial dysplasia - alt -- high mag.jpg | UD - high mag. (WC) | |||
Image: Urothelial dysplasia -- very high mag.jpg | UD - very high mag. (WC) | |||
Image: Urothelial dysplasia - CK20 -- intermed mag.jpg | UD - intermed. mag. (WC) | |||
Image: Urothelial dysplasia - CK20 -- high mag.jpg | UD - high mag. (WC) | |||
</gallery> | |||
www: | |||
*[http://pathology.jhu.edu/bladder/image1.cfm?case_number=10&image_number=1 Urothelial dysplasia (jhu.edu)]. | *[http://pathology.jhu.edu/bladder/image1.cfm?case_number=10&image_number=1 Urothelial dysplasia (jhu.edu)]. | ||
| Line 68: | Line 80: | ||
! Ki-67 | ! Ki-67 | ||
! p53 | ! p53 | ||
! p63 ‡ | |||
|- | |- | ||
| Benign (reactive) | | Benign (reactive) | ||
| Line 73: | Line 86: | ||
| -ve <=10% of cells (+/-rare basal cells) | | -ve <=10% of cells (+/-rare basal cells) | ||
| -ve <20% of cells (+/-weak staining) | | -ve <20% of cells (+/-weak staining) | ||
| -ve surface cells | |||
|- | |- | ||
| Urothelial dysplasia | | Urothelial dysplasia | ||
| Line 78: | Line 92: | ||
| +ve >10% of cells (~40% of cases) | | +ve >10% of cells (~40% of cases) | ||
| +ve >=20% of cells (~70% of cases) | | +ve >=20% of cells (~70% of cases) | ||
| -ve surface cells<ref name=pmid19690775>{{Cite journal | last1 = Stepan | first1 = A. | last2 = Mărgăritescu | first2 = C. | last3 = Simionescu | first3 = C. | last4 = Ciurea | first4 = R. | title = E-cadherin and p63 immunoexpression in dysplastic lesions and urothelial carcinomas of the bladder. | journal = Rom J Morphol Embryol | volume = 50 | issue = 3 | pages = 461-5 | month = | year = 2009 | doi = | PMID = 19690775 }}</ref><ref name=OJP>{{Cite journal | last1 = Raheem| first1 = Sayad A.| last2 = Saied | first2 = Abdel N. | last3 = Al Shaer | first3 = Rabee | last4 = Mustafa | first4 = Osama | last5 = Ali | first5 = Ali H. | title = The Role of CK20, p53 and p63 in Differentiation of Some Urothelial Lesions of Urinary Bladder, Immunohistochemical Study | journal = [http://www.scirp.org/journal/ojpathology Open Journal of Pathology] | volume = | issue = 4| pages = 181-193 | month = | year = 2014 | doi = 10.4236/ojpathology.2014.44024 | PMID = | PMC = | url = }}</ref> | |||
|- | |- | ||
| [[Urothelial carcinoma in situ|Urothelial carcinoma in situ]] (UCIS) | | [[Urothelial carcinoma in situ|Urothelial carcinoma in situ]] (UCIS) | ||
| Line 83: | Line 98: | ||
| +ve >10% of cells (~95% of cases) | | +ve >10% of cells (~95% of cases) | ||
| +ve >=20% of cells (~80% of cases) | | +ve >=20% of cells (~80% of cases) | ||
| +ve surface cells<ref name=pmid19690775/><ref name=OJP/> | |||
|} | |} | ||
Note: | |||
*‡ Morphology is considered the gold standard for UCIS versus urothelial dysplasia;{{fact}} however, there is a small literature on [[p63]] for dysplasia versus UCIS that is published in lesser known journals. | |||
==Sign out== | |||
<pre> | |||
Urinary Bladder, Biopsy: | |||
- Urothelial dysplasia, see comment. | |||
- Giant cell reaction and chronic inflammation. | |||
Comment: | |||
The urothelium has moderate CK20 staining that extends to the basement membrane. A p53 stain is negative (<10% staining). A Ki-67 stain shows increased staining (marks 20% of urothelium). A p63 stain shows weak/negative surface staining. | |||
</pre> | |||
===Block letters=== | |||
<pre> | |||
RIGHT URETER (MARGIN), EXCISION: | |||
- UROTHELIAL DYSPLASIA, SEE COMMENT. | |||
- NEGATIVE FOR UROTHELIAL CARCINOMA. | |||
COMMENT: | |||
There is focal non-umbrella cell CK20 staining, 10% (focal) urothelial | |||
p53 staining, and 30% (focal) urothelial Ki-67 staining. The findings | |||
are that of (low-grade) urothelial dysplasia. | |||
</pre> | |||
==See also== | ==See also== | ||